Evoke Wealth’s Tenaya Therapeutics TNYA Stock Holding History

Evoke Wealth’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-656	Closed	-$2K	–	1072
2022 Q3	$2K	Buy	+656	New	+$3.06K	﹤0.01%	1077

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ROTUOC

Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Evoke Wealth's TNYA Position: Q4 2022 in Review

Evoke Wealth sold out of Tenaya Therapeutics (TNYA) in Q4 2022, closing a stake of 656 shares — an estimated $2K sold.

Evoke Wealth first reported a position in TNYA in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 68 funds tracked by Wall St. Rank hold TNYA as of Q4 2022.

Evoke Wealth reported no remaining Tenaya Therapeutics position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 656 Tenaya Therapeutics shares in Q4 2022, an estimated $2K.
Evoke Wealth first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 1 quarter.
Evoke Wealth's Tenaya Therapeutics position peaked at $2K in Q3 2022.
68 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.